1,317 followers
RT @FrontOncology: New research: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma: As the first ora…
RT @FrontOncology: New research: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma: As the first ora…
New research: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma: As the first oral multi-target anti-tumor drug proved for the treatment of patients with advanced liver cancer in 2007, sorafenib has… https://t.co/kmCa